Gimeracil
Back to searchScientific Name: | Gimeracil |
Brand Name: | Teysuno |
Company Owner: | Not Available |
Mechanism Of Action | Gimeracil’s main role within Teysuno is to prevent the breakdown of |
Description of the Drug: | Gimeracil is a DPD inhibitor used as an adjunct to antineoplastic therapy to increase the systemic concentrations and therapeutic effectiveness of other antineoplastic agents. |
Protein Data Bank: | Not Available |
Source: DrugBank Online – DrugBank.com. Retrieved 2023-01-23 from https://go.drugbank.com/drugs/DB09257